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5. Summary 
Microglia significantly contribute to the glioma tumor mass by infiltrating primary 
tumor mass (Fig 5.1. A). The net effect of microglial abundance in gliomas is tumor 
promoting by inducing the glioma invasiveness (Fig 5.1. B). The result of microglia-
glioma cross-talk is escalation of MMP-2 activation and that leads to increased 
brakedown of ECM proteins which can explain increase of glioma invasiveness (Fig 
5.1. C-D). Glioma release a factor which stimulates the production of a major MMP-2 
activator- MT1-MMP in microglia. Moreover, the expression of MT1-MMP is 
mediated by p38 MAPK, which makes this kinase a possible target for therapy of 
invasive gliomas (Fig 5.1. D).  
 
 
Fig. 5.1. Microglia-glioma interaction. A-B. Microglia are aggregating at the glioma 
inoculum in organotypical brain slice cultures and their presence increases invasiveness of glioma 
cells. C. Microglia-glioma cross-talk (enlarged from B). Microglia and glioma cell are close to each 
other and gliomas are releasing large amounts of inactive proMMP-2. D. Glioma cell releases a factor 
which stimulates, via p38 MAPK activation, expression of MT1-MMP. Finally, as a result of MT1-
MMP over-expression the large amounts of active MMP-2 are released, which are in turn degrading 
ECM proteins and thereby increase the glioma invasiveness. 
 
The role of microglia in glioma invasiveness                                                               5  
 
I.List of figures 
 
Fig. 1.1. Six essential alterations leading to cancer     9 
Fig. 1.2. Microglial developmental stages      13 
Fig. 1.3. Activation cascade of MMP-2      22 
Fig. 2.1. Restriction map and Multiple Cloning Site (MCS) of pEGFP-N1 vector   34 
Fig. 2.2. FACS of the EGFP expressing glioma cells    37 
Fig. 3.1. Microglia are depleted in cultured brain slices after clodronate liposomes 
treatment          47 
Fig. 3.2. Microglia is present and equally distributed in organotypical brain slice 
cultures and absent in organotypical brain slice cultures treated with clodronate 
liposomes          48 
Fig. 3.3. Clodronate liposome treatment does not alters cell death in GL261 cells   49 
Fig. 3.4. Astrocytes are in a resting state 72h after clodronate liposome treatment of 
organotypical brain slice cultures       51 
Fig. 3.5. Morphology of astrocytes and neurons in organotypical brain slice cultures 
remain unchanged after clodronate liposome treatment    52 
Fig. 3.6. Detection of glioma cells inoculated into cultured brain slices  54 
Fig. 3.7. Attributes of human glioblastomas are reflected in organotypical brain slice 
cultures experimental gliomas       55 
Fig. 3.8. GL261 and F98 cells are more invasive in normal (control) organotypical 
brain slice culturesas compared to microglia depleted organotypical brain slice 
cultures          57 
Fig. 3.9. Density of microglial cells correlates with increased invasive potential of 
glioblastoma cells         59 
Fig. 3.10. LPS treatment does not increase tumor size in organotypical brain slice 
cultures          61 
Fig. 3.11. Supernatant from glioma induce MMP-2 activation by microglia 64 
Fig. 3.12. ProMMP-2 from GL261 cells is activated by microglia   65 
Fig. 3.13. Iba-1 positive cells overexpress MT1-MMP when associated with 
experimental gliomas         66 
Fig. 3.14. Transcription of MT1-MMP after GL261 conditioned medium (GCM) 
treatment is up-regulated        67 
The role of microglia in glioma invasiveness                                                               6  
 
Fig. 3.15. Increased protein expression and turnover of MT1-MMP after GL261 
conditioned medium (GCM) stimulation      67 
Fig. 3.16. MT1-MMP activity increase after GL261 conditioned medium (GCM) 
treatment is mediated by p38 MAPK       68 




II. List of tables 
 
Table 1.1. In vivo states of microglia biology and the associated phenotypic 
characteristics          15 
Table 1.2. Matrix Metalloproteinase family members    20 
Table 2.1. Distribution of increasing concentrations of G418 in a 24-well plate 35 
Table 2.2. Concentration gradient of Lipofectamine 2000 for a transfection in a 6-well 
plate           36 
Table 2.3. Composition of 1% Gelatin 7,5% SDS Polyacrylamide gels  43 
Table 2.4. Composition of 10% SDS Polyacrylamide gels    44 
 
The role of microglia in glioma invasiveness                                                               7  
 
 
III. List of abbreviations 
 
Blood brain barrier (BBB) 
Carbon dioxide (CO2) 
Enhanced green fluorescent protein (EGFP) 
Enzyme-linked immunosorbent assay (ELISA) 
Extracellular matrix (ECM) 
Extracellular regulated kinase ½ (ERK1/2) 
Fluorescence Assisted Cell Sorting (FACS) 
For example, exempla gratia (e.g.) 
Glial fibrilary acidic protein (GFAP) 
Green fluorescent protein (GFP) 
Griffonia simplicifolia isolectin B4 (IL-B4) 
Horseredish peroxidase (HRP) 
Intra-peritoneal (i.p.) 
Lypopolysaharide (LPS) 
Matrix metalloproteinase (MMP) 
Matrix metalloproteinase nine (MMP-9) 
Matrix metalloproteinase two (MMP-2) 
Membane type of matrix metalloproteinase type one (MT1-MMP) 
Mitogen activated protein kinase (MAPK) 
Polymerase chain reaction (PCR)  
Reverse transcriptase PCR (RT-PCR) 
Revolutions per minute (rpm) 
Room temperature (RT) 
Sodium dodecul sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 






Name and surname     Darko Marković 
Birth date                      25.07.1975. 
Birthplace                     Belgrade, Yugoslavia                   
 
 
EDUCATION   
 
• 2003, post graduate student in MD/PhD Neuroscience Program at the 
Charite- Humboldt University in Berlin. 
 
• 2001, Medical Doctor degree obtained at Faculty of Medicine Belgrade , with 
average grade 8.7 ( scale of 10.0 ).  




•  2002  until  now, working at Department for Cellular 
Neurosciences in Max-Delbrück-Centrum für Moleculare 
Medizin as a member of Prof. Kettenmann  working group.  I 
work in the field of Neurooncology and Immunology. For my 
work I use regular cell  and molecular biology techniques, 
immunocytochemistry and imaging techniques. 
•  2001-2002 ,  I  was working in one of the best hospitals in 
Yugoslavia- Military Medical Academy (VMA), beside my 
regular activities there, as a General practice doctor, I  
volunteered in laboratories at Experimental Medicine department 
in order to get familiar with ordinary and scientific lab work. 
 
 




I would like to thank my supervisor Prof. Dr. Helmut Kettenmann for giving me 
opportunity to work on this particular subject in his laboratory. I am grateful for all 
the support and advise.  
 
I also wish to thank Dr. Rainer Glass and Dr. Michael Synowitz for their immense 
support in my PhD study, for helpful suggestions and critical comments. 
 
I also thank Prof. Dr. Bozena Kaminska and Marcin Sliwa for the fruitful 
collaboration. 
 
Furthermore, I would like to thank all former and present members and techichal 
assistance of Cellular Neurosciences Department for help, friendship and support on 
my PhD work. 
 
I would like to name everybody who kindly contributed to my PhD study and my 
thesis, but the list would be endless. Thus, I apologize to everyone reading these lines 
not to be mentioned personally. 
 
Special thanks to International Graduate Program Medical Neuroscience of the Berlin 
Medical University-Charité. 
 
Much gratitude to my mother and sister for the spiritual support and understanding 
during my work on the PhD thesis. 
 
Finally, many thanks to my wife for support and understanding. Mille grazie Phoebe! 




Ich versichere an Eides statt, dass ich die vorligende Dissertation 
 
The role of microglia in glioma invasiveness 
 
Selbst und ohne unzulässige Hilfe Dritter verfast habe, dass sie auch in Teilen keine 
Kopie anderer Arbeiten darstelt und die benuzten Hilfsmittel sowie die Literatur 
vollständig angegeben sind. 
 
 
 
 
 
 
Berlin, den 
 
 
 
 
 
 
 
 
Darko Markovic 
